LeMaitre Vascular (LMAT) reported Q4 earnings late Thursday of $0.49 per diluted share, up from $0.38 a year earlier.

Analysts polled by FactSet expected $0.49.

Net sales in the three months ended Dec. 31 rose to $55.7 million from $48.9 million a year earlier.

Analysts surveyed by FactSet expected $56 million.

The company expects Q1 EPS of $0.48 to $0.53 on sales of $56.7 million to $58.7 million. Analysts expect EPS of $0.51 on sales of $58.1 million.

The company projects 2025 EPS of $2.15 to $2.32 on sales of $235.4 million to $242.8 million. Analysts forecast EPS $2.16 on sales of $240.2 million.

The company increased the quarterly dividend by $0.04 to $0.20 a share, payable March 27 to investors of record March 13.

Shares of the company fell 7.8% in after-hours trading.